Because compliance usually finds you first.

ComplianceGuard exists to put the FDA's public enforcement record in the hands of the brands it affects — before a warning letter makes it matter.

How we choose to work.

Four commitments that shape every scan, report, and rewrite we deliver.

Evidence over fear

Every finding is tied to a specific quote on your site and a specific FDA enforcement pattern. We don't sell panic — we surface facts you can act on.

No legal overreach

We are not a law firm and we don't pretend to be. Our reports are informational risk scans, clearly labeled as such. Legal decisions should go to a qualified attorney.

Honest data and numbers

We publish the actual sizes of our data and results — 2,039 records, 92 brands scanned, 44 missing DSHEA disclaimers. No rounded-for-effect statistics.

Fast turnaround

Compliance questions don't wait for a quarter to pass. Our pipeline delivers a risk-scored report within 48 hours of receiving your URL.

The problem was never a secret.

FDA enforcement is, by law, public. Every warning letter, recall, and enforcement action is published through the openFDA API and mirrored on FDA.gov. The information a brand needs to understand its regulatory exposure is sitting in the open — it's just scattered across thousands of records, in formats built for analysts, not founders.

Meanwhile, most brands don't learn they have a violation until a letter arrives. By then the failure mode is fixed in place: a disease claim on a product page, a structure-function statement with no disclaimer, a marketing line that was never compliant from the day it shipped. The gap isn't legality — it's visibility.

We built ComplianceGuard to close that gap. We pull the public docket and turn it into a per-brand risk map: your public pages on one side, what the FDA has already punished on the other. Instead of a wall of raw records, you get a short list of the specific claims on your own site that look like the ones regulators have acted on.

It's a small, distributed team of regulatory-data engineers and copy specialists. We're not regulators, and we're not lawyers. We're a reading layer on top of public data — built to give brands a fair, fast look at where they actually stand.

From a public URL to a risk-scored report.

The pipeline runs in four stages. Each one is built to keep the output grounded in real, verifiable information rather than generalization:

  1. Fetch public pages. We retrieve the pages you submit — homepage, product pages, about page — and read only content that is already publicly available.
  2. Extract claims. A multi-model AI pipeline with specialized roles for classification, copy generation, and reasoning reads each page and extracts health claims, structure-function statements, and disclaimer coverage.
  3. Cross-reference the docket. Every extracted finding is compared against our index of 2,039 openFDA enforcement records in food, drug, and device categories, refreshed from api.fda.gov on 2026-10-17.
  4. Produce the report. You receive a risk-scored inventory (1–10 per finding) with the supporting evidence quote and a compliant rewrite where one is possible.
This process produces informational risk findings only. It is not legal advice, and it does not create an attorney–client relationship. For legal opinion, consult a regulatory attorney.

A short, honest timeline.

October 2026

FDA docket indexed, first audits delivered

We indexed 2,039 real openFDA enforcement records across food, drug, and device categories and delivered our first compliance risk audits.

October 2026

92 brands scanned

Across supplement, food, and wellness brands, we scanned 92 public sites — 44 of which were missing DSHEA disclaimers on active health claims.

October 2026

Risk Scan product launched

We launched the $149 Risk Scan so any brand could get a fast, affordable first look at its exposure without committing to a full audit.

Want to see where you stand?

Send us your URL and we'll come back within one business day with how a scan works and what it would cover.

Talk to us →